Tag Archives: MCRB

Top 10 Heal Care Stocks To Own Right Now

New York, NY, based Investment company Towerview Llc buys Alico Inc, Prism Technologies Group Inc, sells Belmond during the 3-months ended 2017-03-31, according to the most recent filings of the investment company, Towerview Llc. As of 2017-03-31, Towerview Llc owns 29 stocks with a total value of $214 million. These are the details of the buys and sells.

New Purchases: PRZM, Added Positions: ALCO, BRT, AVIR, Reduced Positions: SGA, BEL, LE, RNWK, GASS, GCVRZ,

For the details of TOWERVIEW LLC’s stock buys and sells, go to www.gurufocus.com/StockBuy.php?GuruName=TOWERVIEW+LLC

These are the top 5 holdings of TOWERVIEW LLCTejon Ranch Co (TRC) – 2,795,000 shares, 28.55% of the total portfolio. Saga Communications Inc (SGA) – 1,196,723 shares, 28.51% of the total portfolio. Shares reduced by 1.22%Barnes & Noble Inc (BKS) – 2,375,000 shares, 10.25% of the total portfolio. Corning Inc (GLW) – 600,000 shares, 7.56% of the total portfolio. Barnes & Noble Education Inc (BNED) – 1,340,000 shares, 6% of the total portfolio. New Purchase: Prism Technologies Group Inc (PRZM)

Towerview Llc initiated holdings in Prism Technologies Group Inc. The purchase prices were between $0.29 and $1.02, with an estimated average price of $0.48. The stock is now traded at around $0.91. The impact to the portfolio due to this purchase was 0.05%. The holdings were 150,000 shares as of 2017-03-31.

Top 10 Heal Care Stocks To Own Right Now: Shell Midstream Partners, L.P.(SHLX)

Advisors’ Opinion:

  • [By Matthew DiLallo]

    Most investors have probably heard of energy giants Royal Dutch Shell (NYSE:RDS-A) (NYSE:RDS-B), Dominion Energy (NYSE:D), and TransCanada (NYSE:TRP). Fewer, however, are likely familiar with their publicly traded master limited partnerships (MLPs): Shell Midstream Partners (NYSE:SHLX), Dominion Energy Midstream Partners (NYSE:DM), and TC Pipelines (NYSE:TCP). That might be a good thing, as the market has beaten up the latter trio this year, sending their valuations south.

Top 10 Heal Care Stocks To Own Right Now: American Capital Agency Corp.(AGNC)

Advisors’ Opinion:

  • [By Amanda Alix]

    This development will likely give battered mREITs like Annaly Capital (NYSE: NLY  ) , Armour Residential (NYSE: ARR  ) , and American Capital Agency (NASDAQ: AGNC  ) a huge boost as investors begin to feel less panic regarding a tapering of the current QE3 program. Markets have responded to the Summers announcement by soaring skyward, apparently feeling relief and confidence about the fate of the taper.

  • [By Amanda Alix]

    It was just about one year ago that QE3 made its debut, and mortgage REITs, particularly agency-only players like Annaly Capital (NYSE: NLY  ) , Armour Residential (NYSE: ARR  ) , and American Capital Agency (NASDAQ: AGNC  ) began moaning about the increased competition for mortgage-backed securities guaranteed by Fannie Mae and Freddie Mac.

  • [By Boniface Murigu]

    It’s no secret that mREITs such as American Capital Agency (NASDAQ: AGNC  ) (NASDAQ: AGNC  ) (NASDAQ: AGNC  ) , Annaly Capital Management (NYSE: NLY  ) (NYSE: NLY  ) (NYSE: NLY  ) ,and CYS Investmentshave gone through a very turbulent trading period, with all major players losing a sizable share of market value.

Top 10 Heal Care Stocks To Own Right Now: New Century Bancorp Inc.(NC)

Advisors’ Opinion:

  • [By Lisa Levin]

    Shares of NACCO Industries, Inc. (NYSE: NC) got a boost, shooting up 11 percent to $73.85. NACCO Industries disclosed that its subsidiary Hamilton Beach Brands has filed to trade as an independent company. The company announced the retirement of its CEO following Hamilton Beach Brands spin off.

  • [By Stephan Byrd]

    Whirlpool (NYSE: WHR) and NACCO Industries (NYSE:NC) are both consumer discretionary companies, but which is the superior stock? We will contrast the two companies based on the strength of their profitability, valuation, risk, dividends, institutional ownership, analyst recommendations and earnings.

Top 10 Heal Care Stocks To Own Right Now: Medidata Solutions, Inc.(MDSO)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on Medidata Solutions (MDSO)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Lisa Levin]

    On Wednesday, technology shares climbed by 0.94 percent. Top gainers in the sector included Marvell Technology Group Ltd. (NASDAQ: MRVL) and Medidata Solutions Inc (NASDAQ: MDSO).

  • [By Peter Graham]

    A long term performance chart shows shares of Veeva Systems outperformingunderperforming small cap peerModel N Inc (NYSE: MODN) while mid cap Medidata Solutions (NASDAQ: MDSO) has been a huge outperformer that has just moved past its 2014 peak:

Top 10 Heal Care Stocks To Own Right Now: Masonite International Corporation(DOOR)

Advisors’ Opinion:

  • [By Matt Hogan]

    Masonite International Corp (NYSE: DOOR) supplies exterior and interior doors primarily to the North American residential market. There are in a great position to profit from both new construction and the repair, renovation, and remodel ("RRR") trends of a hot real estate market.

  • [By Max Byerly]

    Masonite International (NYSE:DOOR) – Wedbush dropped their Q2 2018 earnings per share (EPS) estimates for shares of Masonite International in a note issued to investors on Monday, May 7th. Wedbush analyst J. Mccanless now expects that the company will post earnings per share of $1.02 for the quarter, down from their prior forecast of $1.04. Wedbush currently has a “Neutral” rating and a $70.00 target price on the stock. Wedbush also issued estimates for Masonite International’s Q3 2018 earnings at $1.16 EPS, Q4 2018 earnings at $1.03 EPS, FY2018 earnings at $3.93 EPS, Q1 2019 earnings at $0.92 EPS, Q2 2019 earnings at $1.24 EPS, Q3 2019 earnings at $1.39 EPS, Q4 2019 earnings at $1.25 EPS and FY2019 earnings at $4.80 EPS.

Top 10 Heal Care Stocks To Own Right Now: Seres Therapeutics, Inc.(MCRB)

Advisors’ Opinion:

  • [By Lisa Levin]

    Seres Therapeutics Inc (NASDAQ: MCRB) shares shot up 35 percent to $12.51. Seres Therapeutics reported initiation of new SER-019 study announced FY16 loss of $2.30 per share on revenue of $21.766 million.

  • [By Lisa Levin] Gainers
    Trevena Inc (NASDAQ: TRVN) rose 10.8 percent to $3.60 in pre-market trading after dropping 4.97 percent on Wednesday.
    Yum China Holdings Inc (NYSE: YUMC) rose 10.2 percent to $31.05 in pre-market trading after the company reported upbeat earnings for its first quarter.
    Seres Therapeutics Inc (NASDAQ: MCRB) rose 9.1 percent to $11.39 in pre-market trading after dropping 5.26 percent on Wednesday.
    Plug Power Inc (NASDAQ: PLUG) rose 8.9 percent to $2.45 in pre-market trading after surging 73.08 percent on Wednesday.
    Coach Inc (NYSE: COH) rose 6.7 percent to $41.98 in pre-market trading. Coach named Ian Bickley as President, Global Business Development and Strategic Alliances.
    Sapiens International Corporation N.V. (NASDAQ: SPNS) shares rose 6.1 percent to $13.91 in pre-market trading after gaining 0.54 percent on Wednesday.
    Jazz Pharmaceuticals plc (NASDAQ: JAZZ) rose 6.1 percent to $149.15 in pre-market trading. Jazz Pharma reached a settlement with Hikma Pharma related to Xyrem patent case. Mizuho downgraded Jazz from Buy to Neutral.
    Interactive Brokers Group, Inc. (NASDAQ: IBKR) shares rose 6 percent to $36.72 in pre-market trading after declining 0.03 percent on Wednesday.
    Rewalk Robotics Ltd (NASDAQ: RWLK) rose 5.3 percent to $2.00 in pre-market trading after the company disclosed that the U.S. Department of Veterans Affairs purchased 28 added Exoskeleton Systems.
    Merrimack Pharmaceuticals Inc (NASDAQ: MACK) rose 5.1 percent to $3.29 in pre-market trading. Merrimack declared a $1.06 special dividend.
    BioTime, Inc. (NYSE: BTX) shares rose 4.8 percent to $3.50 in pre-market trading. BioTime, reported the formation of new subsidiary AgeX Therapeutics, Inc.
    Akari Therapeutics PLC (ADR) (NASDAQ: AKTX) shares rose 4.8 percent to $12.26 in pre-market trading after gaining 0.69 percent on Wednesday.
    Bed Bath & Beyond Inc. (NASDAQ: BBBY) rose 3.6 percent to $39.15 in pre-market trading after the company posted better-than
  • [By Lisa Levin]

    Seres Therapeutics Inc (NASDAQ: MCRB) shares dropped 70 percent to $10.69 after the company reported interim results from SER-109 Phase 2 ECOSPOR study in multiply recurrent clostridium difficile infection. The study did not achieve primary endpoint.

Top 10 Heal Care Stocks To Own Right Now: Euro/Yen(EJ)

Advisors’ Opinion:

  • [By Belinda Cao]

    E-House China Holdings Ltd. (EJ), a real estate brokerage, gained 9.2 percent to $9.70, extending it advance to a third week. Its American depositary receipts retreated 3.1 percent Sept. 20 from the highest level since May 2011.

Top 10 Heal Care Stocks To Own Right Now: Apollo Investment Corporation(AINV)

Advisors’ Opinion:

  • [By Lisa Levin] Gainers
    Portola Pharmaceuticals, Inc. (NASDAQ: PTLA) rose 34.7 percent to $45.50 in pre-market trading following news that the FDA has approved Andexxa for the reversal of factor Xa inhibitors.
    Euro Tech Holdings Company Limited (NASDAQ: CLWT) rose 15.7 percent to $6.65 in pre-market trading after climbing 155.56 percent on Thursday.
    China Recycling Energy Corporation (NASDAQ: CREG) rose 14.7 percent to $2.75 in pre-market trading after climbing 57.89 percent on Thursday.
    Pandora Media, Inc. (NYSE: P) rose 11 percent to $6.40 in pre-market trading after reporting strong quarterly results.
    Fred's, Inc. (NASDAQ: FRED) rose 9.2 percent to $1.90 in pre-market trading following Q4 results.
    Shake Shack Inc (NYSE: SHAK) rose 9.1 percent to $51.70 in pre-market trading after the company reported upbeat results for its first quarter and raised its FY18 guidance.
    Allscripts Healthcare Solutions, Inc. (NASDAQ: MDRX) rose 9 percent to $12.55 in pre-market trading after the company posted Q1 results and agreed to acquire HealthGrid.
    Weight Watchers International, Inc. (NYSE: WTW) rose 7.6 percent to $75 in pre-market trading after the company reported stronger-than-expected results for its first quarter. The company also raised its FY18 earnings outlook from $2.40-$2.70 to $3-$3.20.
    Viavi Solutions Inc. (NASDAQ: VIAV) rose 7.5 percent to $10.15 in pre-market trading following Q3 results.
    Pearson plc (NYSE: PSO) rose 4.5 percent to $11.83 in pre-market trading after reporting strong quarterly earnings.
    Alibaba Group Holding Ltd (NYSE: BABA) shares rose 4.4 percent to $190.50 in the pre-market trading session as the company posted upbeat Q4 results.
    Aqua Metals, Inc. (NASDAQ: AQMS) shares rose 3.9 percent to $4.30 in pre-market trading after gaining 6.98 percent on Thursday.
    Newell Brands Inc (NYSE: NWL) shares rose 3.6 percent to $27.65 in pre-market trading after reporting upbeat quarterly earnings.
    HMS Holdings Corp (NASDAQ: H

Top 10 Heal Care Stocks To Own Right Now: Inovio Pharmaceuticals, Inc.(INO)

Advisors’ Opinion:

  • [By Jim Robertson]

    On Tuesday, small capInovio Pharmaceuticals (NASDAQ: INO) surged 22.63% after announcingthat its synthetic vaccine approach using a collection of synthetic DNA antigens generated broad protective antibody responses against all major deadly strains of H1 influenza viruses from the last 100 years. This includesthe virus that caused Spanish Flu in 1918. The study involvedmultiple animal models, including mice, guinea pigs and non-human primates. Given how bad flu season is this year, the announcement got plenty of attention asthe following technical chart shows:

  • [By Ben Levisohn]

    Shares of Inovio Pharmaceuticals(INO) are climbing today after the biotech company announced that it would begin testing a Zika vaccine in Puerto Rico. Maxim’sJason McCarthy andJason Kolbert have the details:

    CREDIT: Alex Wild Published Credit: Alex Wild Alex Wild

    Inovio announced the initiation of a small clinical study (N=160) of its Zika vaccine, GLS-5700 (being developed with GeneOne Life Sciences), in Puerto Rico. It is estimated by the CDC that the Zika virus could infect more than 25% of the population of Puerto Rico by YE16.The study will evaluate safety, immunogenicity and early signs of efficacy in preventing Zika infection. Data are expected in 2017, and if positive, Inovio will discuss with regulators the best path forward.

    In addition, the phase I study of GLS-5700 (N=40) in the U.S. and Canada, which is the first in-human Zika vaccine study, is now fully enrolled. Data evaluating safety and immunogenicity are expected by YE16.

    Conclusion. With the Zika virus spreading, including to the U.S., there remains an urgent need for a vaccine. Inovio continues to demonstrate that the company’s DNA-based vaccine approach is safe and can rapidly transition to human studies.

    Shares of Inovio Pharmaceuticalshave gained 4.3% to $9.24 at 2:50 p.m. today, while the iShares Nasdaq Biotechnology ETF (IBB) has dipped 0.3% to $284.29.

  • [By William Patalon III]

    In a Private Briefing report in late July, we told you that tiny biotech Inovio Pharmaceuticals Inc. (Nasdaq: INO) had dosed its first patient in a Phase I clinical study to evaluate its synthetic vaccine for the Zika virus.

  • [By Lisa Levin]

    Inovio Pharmaceuticals Inc (NASDAQ: INO) shares were also up, gaining 24 percent to $8.84 following announcement of a clinical study for a HIV vaccine that had nearly 100 percent immune response.

  • [By Keith Speights]

    A quick analysis of Inovio Pharmaceuticals’ (NASDAQ:INO) stock performance history shows plenty of twists and turns — from the company’s early biomedical days to its recent advances in developing a Zika virus vaccine. But this chart shows the story hasn’t been great for investors.

Top 10 Heal Care Stocks To Own Right Now: Real Goods Solar, Inc.(RGSE)

Advisors’ Opinion:

  • [By Peter Graham]

    A long term performance chart shows Vivint Solar Holdings along with small cap solar installation stock Sunrun Inc (NASDAQ: RUN) below their IPO prices while Real Goods Solar, Inc (NASDAQ: RGSE)has imploded after being a highflyer:

  • [By Lisa Levin]

    Shares of Real Goods Solar, Inc. (NASDAQ: RGSE) got a boost, shooting up 22 percent to $2.98 after dropping 7.89 percent on Monday. RGS Energy disclosed that it has completed its $11.5 million public offering of common stock and warrants.

  • [By Ashley Moore]

    Here is a list of the top 10 best small-cap stocks based on price gains per share so far in 2017:

    Company (Ticker)Price per Share% Change AquaBounty Technologies Inc. (Nasdaq: AQB)$14.338,646.99%Rennova Health Inc. (Nasdaq: RNVA)$3.133,333.73%China Gengsheng Minerals Inc. (OTCMKTS: CHGS)$0.021,718.18%Sunshine Heart Inc. (Nasdaq: SSH)$3.851,071.43%CTI BioPharma Corp. (Nasdaq: CTIC)$4.30991.76%Catalyst Biosciences Inc. (Nasdaq: CBIO)$6.22853.85%TearLab Corp. (Nasdaq: TEAR)$4.20707.85%Pulmatrix Inc. (Nasdaq: PULM)$3.86566.10%Real Goods Solar Inc. (Nasdaq: RGSE)$1.43498.75%Calithera Biosciences Inc. (Nasdaq: CALA)$11.70281.54%

  • [By Lisa Levin]

    Shares of Real Goods Solar, Inc. (NASDAQ: RGSE) got a boost, shooting up 15 percent to $1.26 after the company issued a business update. RGS Energy expects Q1 sales of $1.96 million, up from $670,000 in the fourth quarter.

  • [By Peter Graham]

    A long term performance chart shows Vivint Solar Holdings and fellow small cap solar installation stock Sunrun Inc (NASDAQ: RUN) below their IPO prices while Real Goods Solar, Inc (NASDAQ: RGSE)has imploded from its previous highs:

Top 10 Value Stocks For 2018

Investment company PhiloSmith Capital Corp buys Validus Holdings, Black Knight Inc, sells Chubb, Arch Capital Group, First American Financial Corp, Hiscox during the 3-months ended 2017-12-31, according to the most recent filings of the investment company, PhiloSmith Capital Corp. As of 2017-12-31, PhiloSmith Capital Corp owns 30 stocks with a total value of $115 million. These are the details of the buys and sells.

New Purchases: BKI, Added Positions: VR, JRVR, Reduced Positions: PRI, RJF, BRO, AEL, RGA, RLI, Sold Out: CB, ACGL, FAF, HCXLF,

For the details of PhiloSmith Capital Corp’s stock buys and sells, go to www.gurufocus.com/StockBuy.php?GuruName=PhiloSmith+Capital+Corp

These are the top 5 holdings of PhiloSmith Capital CorpPrimerica Inc (PRI) – 106,700 shares, 9.44% of the total portfolio. Shares reduced by 13.04%Reinsurance Group of America Inc (RGA) – 60,550 shares, 8.23% of the total portfolio. Shares reduced by 7.63%Brown & Brown Inc (BRO) – 178,225 shares, 7.99% of the total portfolio. Shares reduced by 7.76%Arthur J. Gallagher & Co (AJG) – 143,725 shares, 7.93% of the total portfolio. Mentor Graphics Corp (MENT) – 47,700 shares, 7.04% of the total portfolio. Shares reduced by 17.33%New Purchase: Black Knight Inc (BKI)

PhiloSmith Capital Corp initiated holdings in Black Knight Inc. The purchase prices were between $42 and $46.85, with an estimated average price of $45.2. The stock is now traded at around $46.70. The impact to the portfolio due to this purchase was 1.3%. The holdings were 33,881 shares as of 2017-12-31.

Top 10 Value Stocks For 2018: Brunswick Corporation(BC)

Advisors’ Opinion:

  • [By Stephan Byrd]

    ILLEGAL ACTIVITY WARNING: “$1.15 Billion in Sales Expected for Brunswick Co. (BC) This Quarter” was first reported by Ticker Report and is the sole property of of Ticker Report. If you are reading this story on another publication, it was illegally stolen and reposted in violation of U.S. and international trademark & copyright law. The correct version of this story can be viewed at www.tickerreport.com/banking-finance/3380347/1-15-billion-in-sales-expected-for-brunswick-co-bc-this-quarter.html.

  • [By Shane Hupp]

    Get a free copy of the Zacks research report on Brunswick (BC)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 10 Value Stocks For 2018: New Media Investment Group Inc.(NEWM)

Advisors’ Opinion:

  • [By Joseph Griffin]

    New Media Inv Group (NYSE: NEWM) and News (NASDAQ:NWS) are both consumer staples companies, but which is the superior stock? We will compare the two companies based on the strength of their dividends, analyst recommendations, earnings, profitability, valuation, risk and institutional ownership.

Top 10 Value Stocks For 2018: Biotricity (BTCY)

Advisors’ Opinion:

  • [By Robert J. Smith]

    Biotricity (OTCBB: BTCY) is a comer in the rapidly growing medical device market and is a small cap to take notice of. Driving this lucrative market are; IoT-driven device connectivity, governmental pressure to cut healthcare costs, escalating hospital costs, a need to reduce hospital readmission rates, an aging population, and a high rate of people with chronic disease. The largest factor driving this market is the rapidly growing rate of those afflicted with chronic disease.

  • [By James E. Brumley]

    Biotricity Inc (OTCMKTS:BTCY), a developer of remote health-monitoring devices, reminded us not so gently today that while it’s waiting on the last of the necessary approvals from the FDA for its hardware, it’s still moving the ball downfield (so to speak). That is to say, it’s already lined up a manufacturer for its so-called Bioflux cardiac monitor for when the last green light is given, and it’s a good one…. Providence Enterprise . That’s the same company that makes some of the equipment and goods within your sight right now.

    Biotricity is the name behind two pieces of technology, both of which are nearing the end of their development. One is the aforementioned Bioflux, and the other is called biolife…. the latter for use by individuals outside of a clinical setting. Neither is on the market yet, but both are projected to be on the market this year. In fact, the company demonstrated its IoT-connected bioflux at this year’s Mobile World Congress (MWC) 2017 in Barcelona, Spain a couple of weeks ago. The crowd liked what it saw.

    The marketable version of the device isn’t available yet; it’s still going through the approval process. The company recently filed a 510k request with the FDA for its bioflux technology (the 510k path is for medical devices rather than drugs, and as such doesn’t require a lot of regulatory deliberation), and has heard back from the FDA about a key part of the device already – it got the green light. Another arm of the FDA must look at other aspects of the device, and that portion of the review takes longer.

    Still, the company is rightfully optimistic, so much so that it’s already lined up a company to manufacture the Bioflux device once the final approval and final specs are in. That company is Providence Enterprise, which has a long history in making drug delivery and diagnostic equipment, as well as plenty of experience making electronics. The Bioflux will be a blend of both capabilities.

    It’s in

  • [By James E. Brumley]

    When an investor thinks of stocks in the cardio-monitoring arena, names like General Electric Company (NYSE:GE) and Medtronic PLC (NYSE:MDT) tend to surface first. And well they should. Medtronic is the largest name dedicated solely to equipment that tells doctors and nurses how well a patient’s heart is functioning, while GE Healthcare smartly leverages the name of its parent company’s recognizable name to win market share in the medical equipment space.

    General Electric and Medtronic aren’t the only names in town, however, and certainly not the top prospects for an investor seeking out a fresh, undiscovered growth opportunity. That honor arguably belongs to an up-and-coming small cap outfit called Biotricity Inc. (OTCMKTS:BTCY), which is nearing its first-ever revenue.

    Don’t look for a Biotricity product quite yet, as they’re not on the market. Consumers as well as investors will want to keep their eyes and ears open for two of them soon though, however, with one of those devices being a high-precision, FDA-approved instrument for use by healthcare workers in a clinical setting. The other device is a consumer-oriented version of the same technology, giving BTCY access to not just one but two crucial markets. Even more recently Biotricity reported it was opening up its development pipeline to the fetal monitoring and sleep apnea markets. Heart-monitoring is the near-term venture, though.

    The two products are called biotricity and biolife (neither moniker is supposed to be capitalized). The latter is a wireless, remote consumer-oriented heart rate and activity monitoring device, and the former is a clinical-grade monitoring device… also wireless and remotely operated/monitored.

    Bioflux is only available by prescription. The bioflux hardware includes an ECG (heart-rhythm) monitoring device, software, and if desired, service from a monitoring lab that performs remote diagnostic monitoring for up to 30 consecutive days at a time. It

  • [By Bryan Murphy]

    As much progress as the remote medical monitoring device market has made in recent years, we’ve still only scratched the surface. The surface has been scratched though. The Dexcom G5 mobile glucose monitor from DexCom, Inc. (NASDAQ:DXCM) is one impressive example. Arguably the first and best entry in the race, DexCom has sent a clear message that consumers and caregivers are ready for a functional device that takes care of itself.

    At the other end of the spectrum is a recent round of products that are less clinical in nature, and more broad-usage friendly. Devices like the Apple Inc. (NASDAQ:AAPL) watch and the Fitbit Inc (NYSE:FIT) line of products are both capable of monitoring heart rates and activity. On the other, neither does it all that well… not like one would expect in a clinical setting. Fitbit has run into a headwind of legal and reputational trouble since it’s been verified that its trackers aren’t all that accurate; Apple avoided such trouble largely because few consumers ever viewed its watches as medical-grade hardware.

    The gap between the Dexcom G5 and the Fitbit fitness trackers, however, is where real opportunity lies. See, the entries to date have proven there is a market for mobile medical devices , but have also proven they have to work as well as the equipment one might expect to find in a doctor’s office or in a hospital.

    It’s this subtle nuance that puts a young company called Biotricity Inc. (OTCMKTS:BTCY) in the spotlight, as it has melded mobile monitoring and quality monitoring, and is now in the midst of making sure they’re marketable… not just to consumers, but to insurance companies (which tend to pay a lot more than the average consumer does). Fitbit missed the mark on both fronts.

    Biotricity is working two different but similar pieces of technology. One is called bioflux, for use by caregivers in a clinical setting, and the other is biolife individuals outside of a clinical setting. Neither is o

Top 10 Value Stocks For 2018: CobalTech Mining Inc. (BNCIF)

Advisors’ Opinion:

  • [By SEEKINGALPHA.COM]

    The other junior cobalt miners include Brixton Metals Corporation (OTC:BXTMD) [TSXV:BBB], Canadian International Minerals [TSXV:CIN], Clean TeQ (OTCPK:CTEQF) [ASX:CLQ], Cobalt Power Group (TSXV:CPO), CobalTech Mining [TSXV:CSK] (OTCPK:BNCIF), Conico Ltd (ASX:CNJ), Corazon Mining Ltd [ASX:CZN], Dragon Energy (ASX:DLE), Highlands Pacific (OTC:HLPCF), Hinterland Metals Inc (TSXV:HMI) (OTC:HNLMF), and LiCo Energy Metals (TSXV:LIC) (OTCQB:WCTXF).

Top 10 Value Stocks For 2018: T2 Biosystems, Inc.(TTOO)

Advisors’ Opinion:

  • [By William Romov]

    Penny Stocks to Buy for December 2017, No. 5: T2 Biosystems Inc. (Nasdaq: TTOO)

    Currently trading at $4.10 per share, T2 Biosystems Inc. (Nasdaq: TTOO) makes diagnostic products for biological in vitro research. It has the highest share price of the penny stocks on our list today.

  • [By Lisa Levin]

    Shares of T2 Biosystems Inc (NASDAQ: TTOO) were down 29 percent to $5.41. T2 Biosystems extended timeline for the completion of the T2Bacteria trial. BTIG downgraded the rating on T2 Biosystems from Buy to Sell, while lowering the price target from $12 to $4.

  • [By Lisa Levin]

    T2 Biosystems Inc (NASDAQ: TTOO) shares were also up, gaining 15 percent to $7.48 after the company disclosed a $40 million equity investment by partner Canon U.S.A.

Top 10 Value Stocks For 2018: Masco Corporation(MAS)

Advisors’ Opinion:

  • [By Lisa Levin] Companies Reporting Before The Bell
    United Technologies Corporation (NYSE: UTX) is estimated to report quarterly earnings at $1.51 per share on revenue of $14.62 billion.
    The Coca-Cola Company (NYSE: KO) is expected to report quarterly earnings at $0.46 per share on revenue of $7.31 billion.
    Caterpillar Inc. (NYSE: CAT) is projected to report quarterly earnings at $2.07 per share on revenue of $11.93 billion.
    Verizon Communications Inc. (NYSE: VZ) is expected to report quarterly earnings at $1.11 per share on revenue of $31.22 billion.
    Lockheed Martin Corporation (NYSE: LMT) is estimated to report quarterly earnings at $3.42 per share on revenue of $11.28 billion.
    The Sherwin-Williams Company (NYSE: SHW) is projected to report quarterly earnings at $3.15 per share on revenue of $3.94 billion.
    Biogen Inc. (NASDAQ: BIIB) is expected to report quarterly earnings at $5.92 per share on revenue of $3.15 billion.
    3M Company (NYSE: MMM) is estimated to report quarterly earnings at $2.52 per share on revenue of $8.26 billion.
    JetBlue Airways Corporation (NASDAQ: JBLU) is projected to report quarterly earnings at $0.2 per share on revenue of $1.75 billion.
    Eli Lilly and Company (NYSE: LLY) is expected to report quarterly earnings at $1.13 per share on revenue of $5.49 billion.
    Harley-Davidson, Inc. (NYSE: HOG) is estimated to report quarterly earnings at $0.88 per share on revenue of $1.25 billion.
    Corning Incorporated (NYSE: GLW) is expected to report quarterly earnings at $0.3 per share on revenue of $2.50 billion.
    Centene Corporation (NYSE: CNC) is projected to report quarterly earnings at $1.88 per share on revenue of $13.28 billion.
    The Travelers Companies, Inc. (NYSE: TRV) is estimated to report quarterly earnings at $2.77 per share on revenue of $6.75 billion.
    Wipro Limited (NYSE: WIT) is expected to report quarterly earnings at $0.07 per share on revenue of $2.16 billion.
    PACCAR Inc (NASDAQ: PCAR) is projected to
  • [By ]

    Masco (MAS) : “I like Masco. We have a housing shortage and that’s good for Masco.”

    Over on Real Money, Cramer says the Netflix  (NFLX) numbers show that cord-cutting is more than palpable. Get more of his insights with a free trial subscription to Real Money.

  • [By WWW.THESTREET.COM]

    Now, while Home Depot (HD) didn’t take off on these figures, Whirlpool (WHR) jumped more than four points. My take? Home Depot becomes a stock to put on your radar screen as we bounce around Dow 20,000. I am partial to Masco (MAS) , the kitchen and bath company, too, off these numbers.

  • [By WWW.THESTREET.COM]

    When companies break up, they can create enormous value, and nowhere is that more evident than with TopBuild (BLD) , the former services arm of Masco (MAS) that began trading as an independent company in July 2015. Since the spinoff, shares of TopBuild have rallied 50% and Cramer said the move is not yet over.

Top 10 Value Stocks For 2018: Seres Therapeutics, Inc.(MCRB)

Advisors’ Opinion:

  • [By Lisa Levin] Gainers
    Trevena Inc (NASDAQ: TRVN) rose 10.8 percent to $3.60 in pre-market trading after dropping 4.97 percent on Wednesday.
    Yum China Holdings Inc (NYSE: YUMC) rose 10.2 percent to $31.05 in pre-market trading after the company reported upbeat earnings for its first quarter.
    Seres Therapeutics Inc (NASDAQ: MCRB) rose 9.1 percent to $11.39 in pre-market trading after dropping 5.26 percent on Wednesday.
    Plug Power Inc (NASDAQ: PLUG) rose 8.9 percent to $2.45 in pre-market trading after surging 73.08 percent on Wednesday.
    Coach Inc (NYSE: COH) rose 6.7 percent to $41.98 in pre-market trading. Coach named Ian Bickley as President, Global Business Development and Strategic Alliances.
    Sapiens International Corporation N.V. (NASDAQ: SPNS) shares rose 6.1 percent to $13.91 in pre-market trading after gaining 0.54 percent on Wednesday.
    Jazz Pharmaceuticals plc (NASDAQ: JAZZ) rose 6.1 percent to $149.15 in pre-market trading. Jazz Pharma reached a settlement with Hikma Pharma related to Xyrem patent case. Mizuho downgraded Jazz from Buy to Neutral.
    Interactive Brokers Group, Inc. (NASDAQ: IBKR) shares rose 6 percent to $36.72 in pre-market trading after declining 0.03 percent on Wednesday.
    Rewalk Robotics Ltd (NASDAQ: RWLK) rose 5.3 percent to $2.00 in pre-market trading after the company disclosed that the U.S. Department of Veterans Affairs purchased 28 added Exoskeleton Systems.
    Merrimack Pharmaceuticals Inc (NASDAQ: MACK) rose 5.1 percent to $3.29 in pre-market trading. Merrimack declared a $1.06 special dividend.
    BioTime, Inc. (NYSE: BTX) shares rose 4.8 percent to $3.50 in pre-market trading. BioTime, reported the formation of new subsidiary AgeX Therapeutics, Inc.
    Akari Therapeutics PLC (ADR) (NASDAQ: AKTX) shares rose 4.8 percent to $12.26 in pre-market trading after gaining 0.69 percent on Wednesday.
    Bed Bath & Beyond Inc. (NASDAQ: BBBY) rose 3.6 percent to $39.15 in pre-market trading after the company posted better-than
  • [By Lisa Levin]

    Seres Therapeutics Inc (NASDAQ: MCRB) shares dropped 70 percent to $10.69 after the company reported interim results from SER-109 Phase 2 ECOSPOR study in multiply recurrent clostridium difficile infection. The study did not achieve primary endpoint.

  • [By Lisa Levin]

    Seres Therapeutics Inc (NASDAQ: MCRB) shares shot up 35 percent to $12.51. Seres Therapeutics reported initiation of new SER-019 study announced FY16 loss of $2.30 per share on revenue of $21.766 million.

Top 10 Value Stocks For 2018: BioDelivery Sciences International Inc.(BDSI)

Advisors’ Opinion:

  • [By Lisa Levin]

    In trading on Tuesday, healthcare shares fell 0.48 percent. Meanwhile, top losers in the sector included MannKind Corporation (NASDAQ: MNKD), down 10 percent, and BioDelivery Sciences International, Inc. (NASDAQ: BDSI) down 10 percent.

  • [By Jim Robertson]

    On Friday, our Elite Opportunity Pronewsletter suggested small cap specialty pharmaceuticalstock BioDelivery Sciences International (NASDAQ: BDSI) as a bullish/long trade:

Top 10 Value Stocks For 2018: Taiwan Semiconductor Manufacturing Company Ltd.(TSM)

Advisors’ Opinion:

  • [By Ashraf Eassa]

    For many years, NVIDIA (NASDAQ:NVDA) has relied on Taiwan Semiconductor Manufacturing Company (NYSE:TSM) to manufacture the graphics chips it designs. Today, most of NVIDIA’s Pascal architecture-based graphics processors — from the GeForce GTX 1060, designed for mainstream PC gamers, all the way through its cutting edge Tesla P100 datacenter accelerators — are manufactured by TSMC.

  • [By Garrett Baldwin]

    Shares of Apple Inc. (Nasdaq: AAPL) may face additional pressure today after another surprise update from one of its biggest suppliers. Austria-based supplier AMS, a maker of optical sensors for the iPhone X, warned that sales for the second quarter will fall by roughly 50% from the first quarter. This comes not long after Taiwan Semiconductor Manufacturing Co. Ltd.(ADR) (NYSE: TSM) offered a lower-than-expected Q2 revenue forecast. Now, Wall Street analysts could soon follow with cuts to iPhone sales forecasts, especially after rival Samsung warned of a slowdown in display panel sales.
    This morning, the European Central Bank announced it will maintain its record-low interest rates and accommodating monetary policy. At a time when the U.S. central bank is raising rates, the ECB failed to provide a timeline on when it will end its massive stimulus package, which features monthly bond purchases of $37 billion.
    Four Stocks to Watch Today: DNKN, QSR, GM, FB
    Hedge fund manager and notable short-seller Jim Chanos is lining up positions against two of the restaurant industry’s best-known firms. Shares of Dunkin Brands Group Inc.(Nasdaq: DNKN) and Restaurant Brands International Inc. (NYSE: QSR), which owns Burger King, were both sliding after Chanos said he was short the firms over sales concerns. The news comes the same morning that DNKN topped Wall Street profit estimates of $0.62 by $0.11. However, DNKN quarterly revenue fell short of expectations.
    Facebook Inc. (Nasdaq: FB) stock doesn’t appear to be facing any significant fallout due to its ongoing data scandal. The social media giant shattered revenue expectations after the bell Wednesday. Shares popped 7% after the company reported a 50% year-over-year revenue surge. The firm reported 1.45 billion daily active users and 2.2 billion monthly users. This was the first earnings report since the Cambridge Analytica scandal that happened in March. Shares are rebounding, as the firm had lost billions in

  • [By ]

    Though it was hardly a secret going into April that iPhone X sales have come under pressure following a strong start, chip giant Taiwan Semiconductor’s (TSM) guidance and earnings call commentary suggests the slump is even more pronounced than many previously believed.

  • [By Ashraf Eassa]

    Contract chip manufacturing giantTaiwan Semiconductor Manufacturing Company(NYSE:TSM) announced that it expects its revenue for the entirety of 2018 to grow by “about 10%” — a downward revision from its previous forecast of between 10% and 15% revenue growth.

Top 10 Value Stocks For 2018: DRDGOLD Limited(DRD)

Advisors’ Opinion:

  • [By Alex McGuire]

    This list ranks gold dividend stocks in the mining sector by dividend yield. And it also includes one of our top gold stock recommendations of 2017…

    Gold Dividend Stock Share Price Year-to-Date Performance Dividend Yield (as of June 30)
    DRDGOLD Ltd. (NYSE ADR: DRD) $3.19 -39.7% 10.24%
    Sibanye Gold Ltd. (NYSE ADR: SBGL) $4.70 -33.4% 5.98%
    Harmony Gold Mining Co. (NYSE ADR: HMY) $1.62 -26.7% 4.56%
    Gold Fields Limited (NYSE ADR: GFI) $3.41 +13.3% 2.73%
    Randgold Resources Ltd. (Nasdaq ADR: GOLD) $87.68 +14.9% 1.89%
    Franco Nevada Corp. (NYSE: FNV) $72.39 +21.1% 1.27%
    Royal Gold Inc. (Nasdaq: RGLD) $76.85 +21.3% 1.25%
    Eldorado Gold Corp. (NYSE: EGO) $2.58 -19.9% 1.16%
    Barrick Gold Corp. (NYSE: ABX) $15.90 -0.5% 0.75%
    Goldcorp Inc. (NYSE: GG) $13.02 -4.4% 0.62%

    Six of the 10 gold stocks listed above have posted negative returns so far in 2017. The main reason behind their losses has to do with gold price volatility.

  • [By Lisa Levin]

    In trading on Wednesday, basic materials shares fell by 1.27 percent. Meanwhile, top losers in the sector included McEwen Mining Inc (NYSE: MUX), down 12 percent, and DRDGOLD Ltd. (ADR) (NYSE: DRD), down 7 percent.

  • [By Lisa Levin]

    Tuesday afternoon, the basic materials sector proved to be a source of strength for the market. Leading the sector was strength from Endeavour Silver Corp (NYSE: EXK) and DRDGOLD Ltd. (ADR) (NYSE: DRD).

Top 5 Undervalued Stocks To Own Right Now

There are countless investing rules, mantras and cliches out there ranging from extremely useful to downright dangerous.

One of the most widely accepted and potentially detrimental to your portfolio is, “Buy low, sell high.”

When taken literally, of course, to make a profit you must sell a stock for more than you paid for it. But the essence of buy low, sell high has become one of the costliest myths on Wall Street.

Investors have been trained to think that “undervalued” stocks have the most upside potential. The problem is that this approach often causes investors to overlook the market’s best-performing stocks in favor of the ones doing the worst. Since underperforming investments usually sport lower valuations, investors tend to think these stocks are the more attractive buys.

Top 5 Undervalued Stocks To Own Right Now: Seres Therapeutics, Inc.(MCRB)

Advisors’ Opinion:

  • [By Lisa Levin] Gainers
    Trevena Inc (NASDAQ: TRVN) rose 10.8 percent to $3.60 in pre-market trading after dropping 4.97 percent on Wednesday.
    Yum China Holdings Inc (NYSE: YUMC) rose 10.2 percent to $31.05 in pre-market trading after the company reported upbeat earnings for its first quarter.
    Seres Therapeutics Inc (NASDAQ: MCRB) rose 9.1 percent to $11.39 in pre-market trading after dropping 5.26 percent on Wednesday.
    Plug Power Inc (NASDAQ: PLUG) rose 8.9 percent to $2.45 in pre-market trading after surging 73.08 percent on Wednesday.
    Coach Inc (NYSE: COH) rose 6.7 percent to $41.98 in pre-market trading. Coach named Ian Bickley as President, Global Business Development and Strategic Alliances.
    Sapiens International Corporation N.V. (NASDAQ: SPNS) shares rose 6.1 percent to $13.91 in pre-market trading after gaining 0.54 percent on Wednesday.
    Jazz Pharmaceuticals plc (NASDAQ: JAZZ) rose 6.1 percent to $149.15 in pre-market trading. Jazz Pharma reached a settlement with Hikma Pharma related to Xyrem patent case. Mizuho downgraded Jazz from Buy to Neutral.
    Interactive Brokers Group, Inc. (NASDAQ: IBKR) shares rose 6 percent to $36.72 in pre-market trading after declining 0.03 percent on Wednesday.
    Rewalk Robotics Ltd (NASDAQ: RWLK) rose 5.3 percent to $2.00 in pre-market trading after the company disclosed that the U.S. Department of Veterans Affairs purchased 28 added Exoskeleton Systems.
    Merrimack Pharmaceuticals Inc (NASDAQ: MACK) rose 5.1 percent to $3.29 in pre-market trading. Merrimack declared a $1.06 special dividend.
    BioTime, Inc. (NYSE: BTX) shares rose 4.8 percent to $3.50 in pre-market trading. BioTime, reported the formation of new subsidiary AgeX Therapeutics, Inc.
    Akari Therapeutics PLC (ADR) (NASDAQ: AKTX) shares rose 4.8 percent to $12.26 in pre-market trading after gaining 0.69 percent on Wednesday.
    Bed Bath & Beyond Inc. (NASDAQ: BBBY) rose 3.6 percent to $39.15 in pre-market trading after the company posted better-than
  • [By Lisa Levin]

    Seres Therapeutics Inc (NASDAQ: MCRB) shares shot up 35 percent to $12.51. Seres Therapeutics reported initiation of new SER-019 study announced FY16 loss of $2.30 per share on revenue of $21.766 million.

  • [By Lisa Levin]

    Seres Therapeutics Inc (NASDAQ: MCRB) shares dropped 70 percent to $10.69 after the company reported interim results from SER-109 Phase 2 ECOSPOR study in multiply recurrent clostridium difficile infection. The study did not achieve primary endpoint.

Top 5 Undervalued Stocks To Own Right Now: Merck & Company, Inc.(MRK)

Advisors’ Opinion:

  • [By Lisa Levin]

    Benzinga's newsdesk monitors options activity to notice unusual patterns. These large volume (and often out of the money) trades were initially published intraday in Benzinga Professional . These trades were placed during Friday’s regular session.

  • [By David Zeiler]

    Pharma stocks shot up in the wake of Donald Trump’s victory. Eli Lilly and Co. (NYSE: LLY) and Merck & Co. (NYSE: MRK) both rose about 6%, while Pfizer Inc. (NYSE: PFE) jumped 7%.

  • [By Cory Renauer]

    A failure in the first of a long slate of pivotal trials puts the future of thisMerck & Co. (NYSE:MRK) partnered program on shaky ground. Luckily, the once-failed candidate isn’t the only iron Incyte has in the fire. Here’s a look at why this stock is a lot more attractive now than you might think.

Top 5 Undervalued Stocks To Own Right Now: Polo Ralph Lauren Corporation(RL)

Advisors’ Opinion:

  • [By Casey Wilson]

    Amazon has been a growing pain in the neck for low-price retailers like Wal-Mart Stores Inc. (NYSE:WMT) for some time, but even high-end specialty stores like Ralph Lauren Corp. (NYSE: RL) have struggled now that Amazon has crept into their sector.

  • [By Casey Wilson]

    Ralph Lauren Corp. (NYSE: RL) just became the latest company to fall victim to the “Retail Ice Age.”

    The 50-year-old American icon announced it shuttered its flagship store at Fifth Avenue and 55th Street in New York City on Tuesday (April 4). It will also close 50 other retail locations by the end of the fiscal year.

  • [By Ben Levisohn]

    Hanesbrands was just one of many retail companies that got shellacked this week. Under Armour (UAA) tumbled 29% after missing earnings forecasts and cutting its guidance, while Deckers Outdoor (DECK) plunged 21% after its earnings missed the Street consensus, and Ralph Lauren (RL) plummeted 13% after its CEO stepped down.

  • [By WWW.THESTREET.COM]

    The sidewalks outside stores like Armani, Dolce & Gabanna, Ralph Lauren (RL) , Gap (GPS) , Prada, Abercrombie & Fitch (AF) , Microsoft (MSFT) and Harry Winston are now lined with metal barricades. The strip commands some of the highest retail rents in the world, with the average annual rent being $3500 per square foot.

  • [By Johanna Bennett]

    Times are tough for Ralph Lauren (RL). Profit and sales are fallingat theiconic clothingcompany, and investors who bet on a turnaround havelost their shirts on the stock. Adding to its troubles,CEO StefanLarsson is departingfollowing a creative clash with the companys namesake and founder.

    Pessimism, meanwhile, appears to be on the rise.

    According to a report by the financial analytics company S3 Partners, short interest in Ralph Lauren has risen since the start of the year, hitting historical levels. And while that short position is expected to keep expanding, bearish sentiments could turn on a dime.

    Ihor Dusaniwsky at S3 Partners writes:

    RL short interest levels, already at historical highs today, should continue to grow if the recent trend continues, but having made almost 23% in 2016 and 14% in 2017, short sellers may be quick to cover their positions and lock in profits if RLs stock price turns against them.

    Short interest in Ralph Lauren fell in 2016 as the stock price fella nd shorts covered positions, netting a return of 22.6%. So far this year, however, the short position as increased $226 million, or 38% to $815 million as of this morning, according to the S3 report.

    Its a profitable day for those short sellers. Todays 11% decline Ralph Laurens stock price on an $815 million short position has added $90 million to the short sellers collective bottom line.

    Ralph Lauren is down 11.5% in recent market actions to $77.26 a after earlier falling as low as $76.86 a share. Thats the lowest price for the stock since 2010.

Top 5 Undervalued Stocks To Own Right Now: Tableau Software, Inc.(DATA)

Advisors’ Opinion:

  • [By Monica Gerson]

    Benzinga's newsdesk monitors options activity to notice unusual patterns. These large volume (and often out of the money) trades were initially published intraday in Benzinga Professional . These trades were placed during Monday’s regular session.

    Pier 1 Imports Inc (NYSE: PIR) Dec16 5.0 Puts Sweep: 1191 @ ASK $0.80: 1354 traded vs 102 OI: $5.32 Ref
    Alcoa Inc (NYSE: AA) Jul16 9.5 Puts Sweep: 1494 @ ASK $0.13: 14k traded vs 6682 OI: $10.09 Ref
    Sarepta Therapeutics Inc (NASDAQ: SRPT) Jul16 10.0 Puts: 3536 @ ASK $0.50: 5506 traded vs 54k OI: Earnings 8/4 $22.50 Ref
    Tableau Software Inc (NYSE: DATA) Jul16 47.5 Puts Sweep: 837 @ ASK $0.30: 995 traded vs 37 OI: Earnings 8/3 $50.60 Ref
    Yandex NV (NASDAQ: YNDX) Aug16 18.0 Puts Sweep: 532 @ ASK $0.30: 2143 traded vs 78 OI: Earnings 7/28 Before Open $22.02 Ref
    Wolverine World Wide, Inc. (NYSE: WWW) Aug16 22.5 Puts: 719 @ ASK $1.35: 1032 traded vs 0 OI: Earnings 7/19 $22.22 Ref
    Conn's Inc (NASDAQ: CONN) Jan17 5.0 Puts Sweep: 605 @ ASK $0.85: 1355 traded vs 3132 OI: $7.16 Ref

    Posted-In: Huge Put PurchasesNews Options Markets

Top 5 Undervalued Stocks To Own Right Now: LightInTheBox Holding Co., Ltd.(LITB)

Advisors’ Opinion:

  • [By Jim Robertson]

    On Friday, our Under the Radar Moversnewsletter suggested small cap China based online retailstockLightinthebox Holding Co (NYSE: LITB) as a long/buy trade:

  • [By Peter Graham]

    Small cap China based online retailstockLightinthebox Holding Co (NYSE: LITB) reportedQ1 2017 earnings as net revenues increased 8.0% to $72.7 million (above the high end of the Company’s guidance of $72.0 million). Net revenues from product sales were $64.8 million versus$61.9 million and net revenues from service and others were $7.9 million versus $5.4 million in the same quarter of 2016. As a percentage of net revenues, service and others accounted for 10.9% during the first quarter of 2017. Total orders of product sales were 1.6 million for the first quarter of 2017 versus1.7 million in the same quarter of 2016 while the total number of product sales customers was 1.2 million versus 1.4 million.

Top 10 Medical Stocks For 2018

Despite staggering increases in drug prices, Americans still aren’t living as long as those in other countries. And the worst part is they’re paying more, too…

One out of every four Americans reported that the cost of healthcare is their primary concern right now, according to a January 2017 Monmouth University poll. In fact, anxiety about paying medical bills now outpaces job and unemployment concerns, as well as worries about paying everyday household bills.

And it’s no wonder: In August, prices for medicine, doctor’s appointments, and health insurance rose at rates not seen since 1984.

Drug costs, in particular, are growing by double and triple digits each year. Back in October 2016, The Fiscal Times reported that specialty drug prices grew 18.9% and are projected to increase another 18.7% this year. Additionally, it reported that generic drug prices are expected to increase another 11% this year after already going up 11.3% in 2016.

Top 10 Medical Stocks For 2018: HP Inc.(HPQ)

Advisors’ Opinion:

  • [By Lisa Levin]

    In trading on Wednesday, technology shares fell 0.11 percent. Meanwhile, top losers in the sector included HP Inc (NYSE: HPQ), down 7 percent, and iRobot Corporation (NASDAQ: IRBT) down 8 percent.

  • [By Alex Cho]

    That being the case, it wouldnt take substantial market share gains for AMD to reverse the multi-year decline in its processor business, as performance/watt is what will drive adoption from key PC makers like Dell, HP Inc (NYSE:HPQ)and Lenovo. AMD hasnt been very competitive in the MPU (microprocessor unit) segment for quite a while, but given the recent node shift to 14nm FinFET over at GlobalFoundries, and mention of new architecture by AMD earlier this year at COMPUTEX Taiwan, I get the impression that performance of Summit Ridge, i.e. Zen will match Skylake and will perhaps come in slightly slower than Kaby Lake.

  • [By Peter Graham]

    Small cap 3D printing stockStratasys, Ltd (NASDAQ: SSYS)reported Q1 earnings before the market opened this morning that met expectations, but shares are falling as much as 10% in premarket trading given the run-up the stock has already had. Stratasys is the largest U.S. manufacturer of 3D printers by revenue whileHP Inc (NYSE: HPQ), which has recently entered the3D printer market,is already number two. Nevertheless,it appears that 3D printing stockshave at least stabilized as the short interest has largely been cleared out.

  • [By Paul Ausick]

    Fourth-quarter 2017 shipments of personal computers (PCs), including desktops and laptops, fell 2% year over year to an estimated 71.56 million units. HP Inc. (NYSE: HPQ) was the volume and market-share leader with worldwide shipments totaling 16.08 million in the quarter and a share of 22.5%. For the full year, worldwide shipments dipped 2.8% to 262.54 million units.

  • [By Teresa Rivas]

    HP Inc. (HPQ) rose to the top of the S&P 500 Wednesday.

    Agence France-Presse/Getty Images

    The shares climbed 48 cents, or 2.7%, to $18.02, compared to the S&P 500, which lost 8.85 points, or 0.38%, to 2344.93.

    HP was helped by data from IDC that showed the firm regained the crown of top PC vendor from rival Levono Group in Q1.

    In addition, Morgan Stanleys Katy Huberty reiterated an Overweight rating on HP and increased her price target to $22 from $19:

    In the past 18 months, HP removed over $1B of excess costs and refocused investment dollars on driving innovation across printing and personal systems. Recent product refreshes, including JetIntelligence laser printers, Sprocket mobile photo printer, and premium and gaming/VR-focused PCs are now driving share gains and a return to top-line growth (total revenue grew 2% and 4% Y/Y in last two fiscal quarters, respectively). By reinventing HP, we believe management is heralding a new era for the company whereby investors can expect greater confidence in top-line stabilization as well as earnings and FCF durability.

    Yesterday, American Airlines(AAL)was the best performing stock in the S&P 500.

Top 10 Medical Stocks For 2018: TRC Companies Inc.(TRR)

Advisors’ Opinion:

  • [By Lisa Levin]

    Shares of TRC Companies, Inc. (NYSE: TRR) got a boost, shooting up 16 percent to $7.53. TRC posted Q4 earnings of $0.20 per share on revenue of $132.3 million.

Top 10 Medical Stocks For 2018: Equinix Inc.(EQIX)

Advisors’ Opinion:

  • [By Lee Jackson]

    This is one of the larger capitalization companies in the data center industry. Equinix Inc. (NASDAQ: EQIX)provides data center services to protect and connect the information assets for the enterprises, financial services companies, and content and network providers primarily in the Americas, Europe, the Middle East, Africa and the Asia-Pacific.

Top 10 Medical Stocks For 2018: Anadarko Petroleum Corporation(APC)

Advisors’ Opinion:

  • [By Matthew DiLallo]

    One of the largest projects is the Saddlehorn Pipeline, which Magellan is building with Plains All American Pipeline (NYSE:PAA) and Anadarko Petroleum (NYSE:APC). Both Plains All American Pipeline and Magellan own 40% of the project, which puts their total investment at $230 million apiece. They expect the project to be fully operational early next year, which is noteworthy given its robust first-year economics. Magellan estimates that it will earn eight times EBITDA on the capital deployed, or roughly $28.8 million in annual EBITDA apiece for Magellan and Plains All American Pipeline on their investment.

  • [By Lisa Levin]

    Shares of Sanchez Energy Corp (NYSE: SN) got a boost, shooting up 28 percent to $11.11. Anadarko Petroleum Corporation (NYSE: APC) announced the sale of Eagleford Shale assets to Sanchez Energy and Blackstone Energy Partners for $2.3 billion.

  • [By WWW.GURUFOCUS.COM]

    For the details of Packer & Co Ltd’s stock buys and sells, go to www.gurufocus.com/StockBuy.php?GuruName=Packer+%26+Co+Ltd

    These are the top 5 holdings of Packer & Co LtdBall Corp (BLL) – 625,005 shares, 7.52% of the total portfolio. Hess Corp (HES) – 2,039,400 shares, 6.78% of the total portfolio. Anadarko Petroleum Corp (APC) – 1,432,600 shares, 6.35% of the total portfolio. Shares added by 14.37%Citigroup Inc (C) – 604,500 shares, 6.34% of the total portfolio. Shares reduced by 11.04%General Electric Co (GE) – 1,118,800 shares, 5.98% o

  • [By Matthew DiLallo]

    While crude prices stumbled into 2016, they found their footing by mid-year and roared back to life, ending the year up about 42%. Those rising prices lifted most oil stocks. However, a handful of large-cap oil stocks rose above the crowd by outperforming crude’s rally. Those top-tier performers wereContinental Resources (NYSE:CLR), Devon Energy (NYSE:DVN), Anadarko Petroleum (NYSE:APC), Pioneer Natural Resources (NYSE:PXD), and Cimarex Energy (NYSE:XEC):

Top 10 Medical Stocks For 2018: Sonoco Products Company(SON)

Advisors’ Opinion:

  • [By Ben Levisohn]

    Deutsche Bank’s Debbie Jones and team contend that Sonoco’s (SON) sale of its plastic-container business to Australia’s Amcor is a sign that M&A is in the offing. They explain why:

    Sonoco announced (9/1) that it is selling its Rigid Plastics Blow Molding operations to Amcor (AMC.AU) for $280M. The transaction price represents a multiple of ~8.0x LTM EBITDA. The business had annual sales of ~$210M and consisted of six production sites in the US and one in Canada. Blow molding operations represented ~10% of Sonocos Consumer Packaging segment sales and EBITDA. The transaction is expected to close in Q4. We expect the proceeds to be used to for M&A focused in flexible packaging, thermoforming and temperature-assured packaging.

    We dont believe Sonoco considered its blow molding operations essential to its growth strategy. This standalone business is also more capital intensive compared to some of its other plastic packaging businesses and SON held a small position in the overall market. Ultimately, the company decided it wants to focus its capital in higher growth platforms. We do not expect the divestment to reduce resin buying scale for Sonoco’s remaining assets given different resin buying. Note that with the divestiture of blow molding and the Canton closures plant (divested in Feb. 2015), this makes the ~$100M reels business the last standalone business in the portfolio, but we do not expect this to be divested in the near-term unless cash is needed for much larger M&A.

    Shares of Sonoco have gained 1.3% to $52.49 at 2:12 p.m. today.

     

Top 10 Medical Stocks For 2018: Utilities Select Sector SPDR ETF (XLU)

Advisors’ Opinion:

  • [By WWW.THESTREET.COM]

    The Dow utility average ended last week at a stabilizing 639.95 after trading as low as 616.19 on Nov. 14. Keep in mind that a “death cross” was confirmed on election day, when the 50-day simple moving average fell below the 200-day simple moving average, indicating that lower prices are likely ahead. The 200-day is now at 666.30. The utility average has returned to my range of key levels of 635.23 and 670.81, which remain magnets for the remainder of 2016. This week’s value level is above the Nov. 14 low at 620.87. Investors seeking the safety of dividends can trade the Utilities Select Sector SPDR Fund (XLU) , which is a basket of 28 utility stocks.

  • [By Craig Jones]

    On CNBC's Options Action, Dan Nathan suggested a bearish options trading idea in Utilities SPDR (ETF) (NYSE: XLU).

    The stock caught his attention, because he noticed a big put options volume last week in the name. He thinks traders should not be in the stock ahead of a possible rate hike.

  • [By ]

    High-yield and traditionally-safe sectors like Utilities, represented by the Utilities Select Sector SPDR (NYSE: XLU), and Consumer Staples, represented by the Consumer Staples Select Sector SPDR (NYSE: XLP), show this relationship with yields.

  • [By Craig Jones]

    Speaking on Bloomberg Markets, Kevin Kelly of Recon Capital Partners suggested that investors with a long position in Utilities SPDR (ETF) (NYSE: XLU) should consider an options strategy that offers protection ahead of the FOMC meeting.

Top 10 Medical Stocks For 2018: American Eagle Outfitters, Inc.(AEO)

Advisors’ Opinion:

  • [By Lisa Levin]

    Shares of American Eagle Outfitters (NYSE: AEO) were down 12 percent to $11.35 after the company posted downbeat quarterly earnings and issued a weak earnings forecast for the current quarter.

  • [By Leo Sun]

    American Eagle Outfitters (NYSE:AEO) trades at 12 times earnings, which is half the industry average of 24 for apparel stores. It pays a forward dividend yield of 3.6%, which is much higher than the S&P 500’s average yield of 2%. That dividend is supported by a payout ratio of 43%, but it hasn’t hiked that payout since 2013.

  • [By Chris Lange]

    American Eagle Outfitters Inc. (NYSE: AEO) released its most recent quarterly results before the markets opened on Thursday. This company joins an increasing number of retailers that saw their earnings fall flat during the fourth quarter. Most recently we saw Dollar Tree and Kroger slip.

Top 10 Medical Stocks For 2018: Principal Financial Group Inc(PFG)

Advisors’ Opinion:

  • [By Ben Levisohn]

    The twenty stocks in Worth’s basket are: Ameriprise Financial (AMP) Bank of America, Banner (BANR), Citigroup, Citizens Financial Group (CFG), East West Bancorp (EWBC), First NBC Bank Holding (FNBC), HFF (HF), KeyCorp(KEY), Legacy Texas Financial Group (LTXB), Lincoln National (LNC), Morgan Stanley, Old National Bancorp (ONB), PacWest Bancorp (PACW), PNC Financial Services Group (PNC), Principal Financial Group (PFG), Stifel Financial (SF), SVB Financial Group (SIVB), TCF Financial (TCB), and Wells Fargo.

Top 10 Medical Stocks For 2018: Seres Therapeutics, Inc.(MCRB)

Advisors’ Opinion:

  • [By Lisa Levin]

    Seres Therapeutics Inc (NASDAQ: MCRB) shares dropped 70 percent to $10.69 after the company reported interim results from SER-109 Phase 2 ECOSPOR study in multiply recurrent clostridium difficile infection. The study did not achieve primary endpoint.

  • [By Lisa Levin]

    Seres Therapeutics Inc (NASDAQ: MCRB) shares shot up 35 percent to $12.51. Seres Therapeutics reported initiation of new SER-019 study announced FY16 loss of $2.30 per share on revenue of $21.766 million.

  • [By Lisa Levin] Gainers
    Trevena Inc (NASDAQ: TRVN) rose 10.8 percent to $3.60 in pre-market trading after dropping 4.97 percent on Wednesday.
    Yum China Holdings Inc (NYSE: YUMC) rose 10.2 percent to $31.05 in pre-market trading after the company reported upbeat earnings for its first quarter.
    Seres Therapeutics Inc (NASDAQ: MCRB) rose 9.1 percent to $11.39 in pre-market trading after dropping 5.26 percent on Wednesday.
    Plug Power Inc (NASDAQ: PLUG) rose 8.9 percent to $2.45 in pre-market trading after surging 73.08 percent on Wednesday.
    Coach Inc (NYSE: COH) rose 6.7 percent to $41.98 in pre-market trading. Coach named Ian Bickley as President, Global Business Development and Strategic Alliances.
    Sapiens International Corporation N.V. (NASDAQ: SPNS) shares rose 6.1 percent to $13.91 in pre-market trading after gaining 0.54 percent on Wednesday.
    Jazz Pharmaceuticals plc (NASDAQ: JAZZ) rose 6.1 percent to $149.15 in pre-market trading. Jazz Pharma reached a settlement with Hikma Pharma related to Xyrem patent case. Mizuho downgraded Jazz from Buy to Neutral.
    Interactive Brokers Group, Inc. (NASDAQ: IBKR) shares rose 6 percent to $36.72 in pre-market trading after declining 0.03 percent on Wednesday.
    Rewalk Robotics Ltd (NASDAQ: RWLK) rose 5.3 percent to $2.00 in pre-market trading after the company disclosed that the U.S. Department of Veterans Affairs purchased 28 added Exoskeleton Systems.
    Merrimack Pharmaceuticals Inc (NASDAQ: MACK) rose 5.1 percent to $3.29 in pre-market trading. Merrimack declared a $1.06 special dividend.
    BioTime, Inc. (NYSE: BTX) shares rose 4.8 percent to $3.50 in pre-market trading. BioTime, reported the formation of new subsidiary AgeX Therapeutics, Inc.
    Akari Therapeutics PLC (ADR) (NASDAQ: AKTX) shares rose 4.8 percent to $12.26 in pre-market trading after gaining 0.69 percent on Wednesday.
    Bed Bath & Beyond Inc. (NASDAQ: BBBY) rose 3.6 percent to $39.15 in pre-market trading after the company posted better-than

Top 10 Medical Stocks For 2018: Facebook, Inc.(FB)

Advisors’ Opinion:

  • [By Adam Levy]

    Facebook (NASDAQ:FB) is a global phenomenon. Even with 1.86 billion monthly active users as of the end of 2016, the company is still growing its user base at a fairly steady clip in the high teens.

  • [By Ravi Bala]

    Although there is a lot of hype surrounding Virtual Reality (VR) and Facebook’s(NSDQ:FB) Oculus Rift, I have to say that this is not a game changer. In fact, it has been around before. Nintendo was one of the first companies to do this with their virtual boy. However, the outing was considered a colossal failure due to the high price and nascent technology. As times have changed, the capabilities of this technology have gotten better. However, pricing may be the ultimate determinant of who succeeds or wins. Here’s why the Oculus acquisition may turn out to be a bad move and may hurt FB stock.

  • [By Money Morning Staff Reports]

    The former – led by Facebook Inc. (Nasdaq: FB) and Twitter Inc. (NYSE: TWTR), for example – are going to get clobbered, while the broader pullback will give savvy investors in the latter a massive and potentially very profitable opportunity.